Immune‐Mediated Mechanisms Potentially Regulate the Disease Time‐Course of Duchenne Muscular Dystrophy and Provide Targets for Therapeutic Intervention
- 18 August 2009
- Vol. 1 (8), 755-768
- https://doi.org/10.1016/j.pmrj.2009.04.010
Abstract
Duchenne muscular dystrophy is a lethal muscle‐wasting disease that affects boys. Mutations in the dystrophin gene result in the absence of the dystrophin glycoprotein complex (DGC) from muscle plas...Keywords
Funding Information
- National Institutes of Health NIH (RO1AR049881)
This publication has 110 references indexed in Scilit:
- Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophyHuman Molecular Genetics, 2008
- Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extractJournal of Applied Physiology, 2008
- N‐Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx miceThe Journal of Physiology, 2008
- Interplay of IKK/NF-κB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophyJournal of Clinical Investigation, 2007
- The effects of glucocorticoid therapy on the inflammatory and Dendritic cells in muscular dystrophiesInternational Journal of Experimental Pathology, 2006
- Duchenne muscular dystrophy: Focus on pharmaceutical and nutritional interventionsThe International Journal of Biochemistry & Cell Biology, 2006
- Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growthThe Journal of cell biology, 2003
- TGF-β antagonists: Why suppress a tumor suppressor?Journal of Clinical Investigation, 2002
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999